Media: Brazilian state intends to study Russian COVID-19 vaccine

By | September 9, 2020
Media: Brazilian state intends to study Russian COVID-19 vaccine

The Brazilian state of Bahia has signed a confidentiality agreement with the Russian side to access data on the Russian coronavirus vaccine “Sputnik V” and intends to conduct its clinical trials, reported the publication Folha de Sao Paolo.
“The Bahia state government signed a confidentiality agreement Tuesday, September 8, to access scientific data on a vaccine against COVID-19 developed in Russia,” the publication said.
According to media reports, Brazil also intends to study the vaccine’s effects on populations with ethnic backgrounds other than Russia. It is noted that for this purpose the regional government will have to obtain permission from the National Agency for Health Supervision (Anvisa) and the National Commission on Research Ethics (Conep).
Media: Brazilian state intends to study Russian COVID-19 vaccine
In early September, the authorities of the Brazilian state of Paraná, based on a bilateral agreement with the Russian Direct Investment Fund, announced that they would start testing Russian COVID-19 vaccine Sputnik-V on 10,000 medical volunteers in October. The agreement with RDIF includes, in addition to the third phase of clinical trials, production and distribution of the drug in Brazil.
The Russian Ministry of Health previously registered the world’s first vaccine for COVID-19 prevention, developed by SICEM Gamaleya and produced jointly with the Russian Direct Investment Fund. Head of RDIF Kirill Dmitriev reported that the fund has received applications from more than 20 countries for a billion doses of domestic coronavirus vaccine. At the same time, he noted that Russia has agreed to produce the vaccine in five countries, the available capacity allows producing 500 million doses per year.

Leave a Reply

Your email address will not be published. Required fields are marked *

twenty − 5 =